Eltrombopag Olamine
- Product NDC
- 60219-1414
- 11-digit product format
- 602191414
- Labeler code
- 60219
- Product ID
- 60219-1414_992e50d5-b6c2-4213-9c7c-ef25c84d0708
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eltrombopag
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA212884
- Marketing category
- ANDA
- Marketing start
- 2026-01-15
- Substance
- ELTROMBOPAG OLAMINE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eltrombopag Olamine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ELTROMBOPAG OLAMINE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4U07F515LG |
| Rxcui | 825421, 825427, 884617, 1245001 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60219-1414-3 | Eltrombopag Olamine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 13 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 60219-1414-3 | 60219141403 | 30 TABLET, FILM COATED in 1 BOTTLE (60219-1414-3) | 2026-01-15 | No | No | Historical |